We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Share
  • Facebook
  • Twitter
  • Linked In
  • Google+
back top
ICRS – Press Release – Society Name Change

1300 members from 70 countries Join ICRS

News

It is with great sadness that we note the sudden passing of our friend and long-time ICRS Fellow Member Prof. Dr. James Richardson from Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry. James has been a longtime active member of our society and great contributor to our field for many years. We will miss him greatly and our thoughts and prayers go out to his family and friends.

Condolences can be sent to Anthony Hollander at A.Hollander(at)liverpool.ac.uk. he will collect and foward in due time.

Ken Zaslav, President ICRS

Prof Dr. James Richardson † (1955-2018)

Prof Dr. James Richardson † (1955-2018)

21/02/2018

BEDFORD, Mass.–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that regulatory authorities in Australia granted approval to MONOVISC®, Anika’s single injection viscosupplement for the treatment of pain associated with osteoarthritis of all synovial joints, including the hip and knee. 

Anika Announces Regulatory Approval for MONOVISC® in Australia

Anika Announces Regulatory Approval for MONOVISC® in Australia

20/10/2017

Clinical trial evidence shows that ACI can improve the symptoms of articular cartilage defects of the knee. There is evidence that it is likely to be more successful in people who haven’t had any previous knee repair surgery, and in people who have very little osteoarthritic damage in the knee. But, it is unclear how well ACI works in the long term compared with microfracture, the most commonly used alternative treatment.

NICE (National Institute for Clinical Excellence) Guidance on ACI

NICE (National Institute for Clinical Excellence) Guidance on ACI

06/10/2017